Twenty-four hour tolbutamide plasma concentration as a phenotypic measure of CYP2C9 activity.
Lee
Craig R
CR
Hawke
Roy L
RL
Pieper
John A
JA
D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000378:metabolism; D065729:Cytochrome P-450 CYP2C9; D005838:Genotype; D006801:Humans; D007004:Hypoglycemic Agents; D010597:Pharmacogenetics / Q000379:methods; D010641:Phenotype; D013997:Time Factors; D014044:Tolbutamide / Q000097:blood / Q000493:pharmacokinetics*
D007004:Hypoglycemic Agents; D014044:Tolbutamide; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases